Loading market dashboard
Anavex Life Sciences Corp.
AVXLHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Anavex Life Sciences Corp. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Sep 2030 | $885.11M | $885.11M - $885.11M | $0.00 | $5.23 | 1 |
| Sep 2029 | $713.06M | $713.06M - $713.06M | $0.00 | $4.66 | 1 |
| Sep 2028 | $348.57M | $348.57M - $348.57M | $0.00 | $2.269 | 1 |
| Sep 2027 | $1.21B | $1.21B - $1.21B | $0.00 | -$0.55 | 1 |
| Sep 2026 | $776.00M | $776.00M - $776.00M | $0.00 | -$0.33 | 1 |
| Sep 2025 | $14.38M | $14.38M - $14.38M | $0.00 | -$0.577 | 2 |
| Sep 2024 | $9.40M | $3.86M - $14.92M | $0.00 | -$0.543 | 2 |